Thrombosis Research
Volume 126, Issue 4 , Pages 337-344 , October 2010

Purified thromboplastin causes haemostatic abnormalities but not overt DIC in an experimental rabbit model

  • Line Olrik Berthelsen

      Affiliations

    • Novo Nordisk A/S, Måløv, Denmark
    • Corresponding Author InformationCorresponding author. Hørdumsgade 15, 1.th, 2450 København SV, Denmark. Tel.: +45 40848869; fax: +45 44434537.
    • ,
  • Annemarie T. Kristensen

      Affiliations

    • Department of Small Animal Clinical Sciences, Faculty of Life Sciences, The University of Copenhagen, Denmark
    • ,
  • Mikael Tranholm

      Affiliations

    • Novo Nordisk A/S, Måløv, Denmark

Received 4 March 2010 ,Revised 31 May 2010 ,Accepted 29 June 2010.

References 

  1. Levi M. Disseminated intravascular coagulation. Crit Care Med. 2007 Sep;35(9):2191–2195
  2. Bick RL. Disseminated intravascular coagulation: a review of etiology, pathophysiology, diagnosis, and management: guidelines for care. Clin Appl Thromb Hemost. 2002 Jan;8(1):1–31
  3. Taylor FB, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001 Nov;86(5):1327–1330
  4. Toh CH, Hoots WK. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost. 2007 Mar;5(3):604–606
  5. Brutzki TC, Kulczycky MJ, Bardossy L, et al. Rapid in vivo induction of leukocyte tissue factor mRNA and protein synthesis following low dose endotoxin administration to rabbits. Hematol J. 2001;2(3):188–195
  6. Uchiyama H, Ohtani H, Hiraishi S, et al. Changes in plasma thrombomodulin antigen in rabbit developing endotoxin-induced disseminated intravascular coagulation and the effect of heparin. Thromb Res. 1992 Mar 1;65(4–5):593–604
  7. Lee SY, Chang SK, Lee IH, et al. Depletion of plasma factor XIII prevents disseminated intravascular coagulation-induced organ damage. Thromb Haemost. 2001 Mar;85(3):464–469
  8. Asakura H, Suga Y, Yoshida T, et al. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats. Blood Coagul Fibrinolysis. 2003 Apr;14(3):221–228
  9. Donati MB, Falanga A. Pathogenetic mechanisms of thrombosis in malignancy. Acta Haematol. 2001;106(1–2):18–24
  10. Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008 Oct;65(4):748–754
  11. Kor-Anantakul O, Lekhakula A. Overt disseminated intravascular coagulation in obstetric patients. J Med Assoc Thai. 2007 May;90(5):857–864
  12. Clarke BJ, Sridhara S, Woskowska Z, et al. Consumption of plasma factor VII in a rabbit model of non-overt disseminated intravascular coagulation. Thromb Res. 2002 Dec 15;108(5–6):329–334
  13. Wiinberg B, Jensen AL, Rojkjaer R, et al. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol. 2005 Dec;34(4):389–393
  14. Olrik BL, Thuri KA, Wiinberg B, et al. Implementation of the ISTH classification of non-overt DIC in a thromboplastin induced rabbit model. Thromb Res. 2009 Sep;124(4):490–497
  15. Sandset PM, Abildgaard U, Pettersen M. A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions. Thromb Res. 1987 Aug 15;47(4):389–400
  16. Bevers EM, Comfurius P, van Rijn JL, et al. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem. 1982 Feb;122(2):429–436
  17. O'Brien PJ. Blood cardiac troponin in toxic myocardial injury: archetype of a translational safety biomarker. Expert Rev Mol Diagn. 2006 Sep;6(5):685–702
  18. Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost. 1988 Feb 25;59(1):101–106
  19. Siller-Matula JM, Plasenzotti R, Spiel A, et al. Interspecies differences in coagulation profile. Thromb Haemost. 2008 Sep;100(3):397–404
  20. Des Prez Roger M. Effects of bacterial endotoxin on rabbit platelets: III. Comparison of platelet injury induced by thrombin and by endotoxin. J Exp Med. 1964 Aug 1;120(2):305–313
  21. Feinstein DI, Marder VJ, Colman RW. Consumptive thrombohemorrhagic disorders. In:  Colman RW,  Hirsch J,  Marder VJ,  Clowes AW,  George JN editor. hemostasis and thrombosis basic principles and clinical practice. Lippincott Williams and Wilkins; 2001;p. 1197–1233
  22. Mesters RM, Florke N, Ostermann H, et al. Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis. Thromb Haemost. 1996 Jun;75(6):902–907
  23. Day KC, Hoffman LC, Palmier MO, et al. Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin-induced intravascular coagulation in the rabbit. Blood. 1990 Oct 15;76(8):1538–1545
  24. Wiinberg B, Jensen AL, Johansson PI, et al. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med. 2008 Mar;22(2):357–365

PII: S0049-3848(10)00362-2

doi: 10.1016/j.thromres.2010.06.022

Thrombosis Research
Volume 126, Issue 4 , Pages 337-344 , October 2010

Article Tools

* Image Usage & Resolution